ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0572

ACR Workgroup to Develop Recommendations for PRO Use in Clinical Care for SLE

Patricia Katz1, Claire Barber2, Ali Duarte-Garcia3, Shivani Garg4, Wambui Machua5, Yesenia Santiago-Casas6, Wendy Rodgers7, Lisa Suter8, Jennifer Ude9, Tracy Johansson9, Christie Bartels10 and Jinoos Yazdany11, 1UCSF, San Rafael, CA, 2University of Calgary, Calgary, AB, Canada, 3Mayo Clinic, Rochester, MN, 4University of Madison, School of Medicine and Public Health, Madison, WI, 5Piedmont Physicians, Rheumatology, Atlanta, GA, 6Integral Rheumatology and Immunology Specialists, Plantation, FL, 7Lupus Foundation of America, Torrance, CA, 8Yale School of Medicine, New Haven, CT, 9American College of Rheumatology, Atlanta, GA, 10University of Wisconsin School of Medicine and Public Health, Madison, WI, 11UCSF, San Francisco, CA

Meeting: ACR Convergence 2022

Keywords: Patient reported outcomes, Quality Indicators, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Abstracts: Measures and Measurement of Healthcare Quality

Session Type: Abstract Session

Session Time: 8:00AM-9:00AM

Background/Purpose: Patient-reported outcome (PRO) measures are not consistently used in clinical settings for patients with systemic lupus erythematosus (SLE). As part of a Centers for Disease Control and Prevention-funded ACR initiative to develop RISE registry digital quality measures for SLE, we sought to develop recommendations for the content of a quality measure related to PRO use in SLE clinical care.

Methods: Figure 1 illustrates the overall study plan. First, an expert panel composed of physician, patient, and researcher representatives conducted a structured literature search to identify PRO domains of greatest importance to people with SLE. Papers that reported the patient’s perspective on important patient-reported domains were identified. Data were extracted from all included studies. In a modified Delphi process, the perceived importance of identified domains was ranked. A patient focus group was also convened to identify and rank the importance of PRO domains. After identifying domains, PRO measures (PROMs) assessing each domain were identified through a structured literature review. Detailed evaluations, including psychometric reviews of use in general settings and specifically in SLE, were conducted for each PROM. In a second Delphi process, the expert panel rated PROMs on content, psychometric quality, and feasibility for use in routine SLE clinical care.

Results: In the structured literature search, 2505 papers were identified. Additional titles were identified by experts or through manual searches. After review of titles and abstracts, 56 papers identifying important PRO domains in SLE were reviewed. Data extracted from each paper included information on identification of patient outcomes or priority of outcomes. 27 papers yielded relevant content. The most frequently mentioned domains were fatigue, pain, social functioning, physical functioning, body image and concerns, and cognition, each of which was mentioned in at least 50% of the papers. The Delphi exercise with expert panelists and the focus group with patients both ranked fatigue, pain, mental health (e.g. depression and anxiety), physical function, and cognition as the top 5 domains for assessment during routine SLE clinical care (Table 1). 47 PROMs were mapped to these domains. Some PROMs were removed from consideration because they had not been used in SLE or had not been used in the past 10 years, required fees for use, or were not available in languages other than English. PROMs retained for each top domain and median ratings by the expert panel for content, psychometric quality, and feasibility of use in clinical settings are shown in Table 2.

Conclusion: Physicians and people with SLE identified 5 key areas for PRO measurement in clinical settings: fatigue, pain, mental health, physical function, and cognition. Measurement tools that were rated highly in terms of content, quality, and feasibility were identified for each domain. Next steps are to develop recommendations for PROs to collect routinely in SLE clinical care, and to develop a quality measure that incorporates this PRO measurement strategy into the RISE registry.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: P. Katz, None; C. Barber, None; A. Duarte-Garcia, None; S. Garg, None; W. Machua, None; Y. Santiago-Casas, None; W. Rodgers, None; L. Suter, None; J. Ude, None; T. Johansson, None; C. Bartels, Pfizer; J. Yazdany, AstraZeneca, Gilead, Bristol-Myers Squibb(BMS), Aurinia, Astra Zeneca, Pfizer.

To cite this abstract in AMA style:

Katz P, Barber C, Duarte-Garcia A, Garg S, Machua W, Santiago-Casas Y, Rodgers W, Suter L, Ude J, Johansson T, Bartels C, Yazdany J. ACR Workgroup to Develop Recommendations for PRO Use in Clinical Care for SLE [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/acr-workgroup-to-develop-recommendations-for-pro-use-in-clinical-care-for-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/acr-workgroup-to-develop-recommendations-for-pro-use-in-clinical-care-for-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology